| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.32B | +4.4% |
| Cost of Revenue | $7.69B | +31.6% |
| R&D Expense | $47.5M | +4.6% |
| SG&A Expense | $365.5M | +29.7% |
| Operating Income | -$1.79B | -1230.9% |
| Interest Expense | $353.5M | +10.9% |
| Pre-tax Income | -$2.14B | -261.0% |
| Income Tax | -$2.4M | -110.7% |
| Net Income | -$2.14B | -247.3% |
| EPS (Basic) | -$18.32 | -217.0% |
| EPS (Diluted) | -$18.32 | -217.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $537.0M | -34.8% |
| Accounts Receivable | $395.3M | -32.5% |
| Inventory | $1.89B | +7.0% |
| Current Assets | $3.76B | +0.2% |
| Total Assets | $6.76B | -2.7% |
| Current Liabilities | $3.57B | +62.3% |
| Long-term Debt | $4.23B | +9.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.12B | -396.4% |
| Capital Expenditures | $152.5M | +3.0% |
| Investing Cash Flow | -$152.4M | -3.1% |
| Financing Cash Flow | $994.5M | +87.1% |
| Free Cash Flow | -$1.27B | -240.7% |
| Stockholders' Equity |
| -$2.62B |
| -424.6% |